Patents by Inventor Theodore E. Whitmore

Theodore E. Whitmore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040029228
    Abstract: Novel methods are disclosed for forming a heterodimeric receptor complex with IL-28R and CRF2-4. The methods may be used for detecting and treating viral infections in in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.
    Type: Application
    Filed: April 18, 2003
    Publication date: February 12, 2004
    Inventors: Scott R. Presnell, Wenfeng Xu, Julia E. Novak, Theodore E. Whitmore, Francis J. Grant, Wayne R. Kindsvogel, Kevin M. Klucher
  • Patent number: 6686448
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular domain of a cell-surface receptor that is expressed in kidneys, pancreas, prostate, adrenal cortex and nervous tissue. The polypeptides may be used within methods for detecting ligands that promote the proliferation and/or differentiation of these organs.
    Type: Grant
    Filed: May 21, 2001
    Date of Patent: February 3, 2004
    Assignee: ZymoGenetics, Inc.
    Inventors: Si Lok, Choon J. Kho, Anna C. Jelmberg, Robyn L. Adams, Theodore E. Whitmore, Theresa M. Farrah
  • Publication number: 20030215838
    Abstract: Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17-containing multimeric or heterodimer cytokine receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. The present invention also includes methods for producing the multimeric or heterodimeric cytokine receptor, uses therefor and antibodies thereto.
    Type: Application
    Filed: January 21, 2003
    Publication date: November 20, 2003
    Inventors: Cindy A. Sprecher, Zeren Gao, Joseph L. Kuijper, Maria M. Dasovich, Francis J. Grant, Scott R. Presnell, Theodore E. Whitmore, Angela K. Hammond, Julia E. Novak, Jane A. Gross, Stacey R. Dillon
  • Publication number: 20030191280
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular domain of a cell-surface receptor that is expressed in kidneys, pancreas, prostate, adrenal cortex and nervous tissue. The polypeptides may be used within methods for detecting ligands that promote the proliferation and/or differentiation of these organs.
    Type: Application
    Filed: May 21, 2001
    Publication date: October 9, 2003
    Applicant: ZymoGenetics, Inc.
    Inventors: Si Lok, Choon J. Kho, Anna C. Jelmberg, Robyn L. Adams, Theodore E. Whitmore, Theresa M. Farrah
  • Patent number: 6573069
    Abstract: The present invention relates to polynucleotide and polypeptide molecules for zmse1, a novel human CRIB protein. The polypeptides, and polynucleotides encoding them, may be used for detecting human chromosomal abnormalities and cancers. The present invention also includes antibodies to the zmse1 polypeptides.
    Type: Grant
    Filed: November 9, 2000
    Date of Patent: June 3, 2003
    Assignee: ZymoGenetics, Inc.
    Inventors: James L. Holloway, Zeren Gao, Theodore E. Whitmore
  • Publication number: 20030096339
    Abstract: Novel polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17, a novel cytokine receptor. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo. The polynucleotides encoding zcytor17, are located on chromosome 5, and can be used to identify a region of the genome associated with human disease states. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.
    Type: Application
    Filed: June 26, 2001
    Publication date: May 22, 2003
    Inventors: Cindy A. Sprecher, Scott R. Presnell, Zeren Gao, Theodore E. Whitmore, Joseph L. Kuijper, Mark F. Maurer
  • Publication number: 20030032167
    Abstract: The present invention relates to zlmda24 polynucleotide and polypeptide molecules. Zlmda24 is a novel cytokine-like polypeptide with an anti-parallel alpha-helical structure. The polypeptides may be used within methods for stimulating the proliferation and/or development of hematopoietic cells in vitro and in vivo. Moreover, zlmda24 polynucleotides, polypeptides and antibodies can be used as a diagnostic to detect the presence of human testis tissue. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.
    Type: Application
    Filed: October 19, 2001
    Publication date: February 13, 2003
    Inventors: Darrell C. Conklin, Zeren Gao, Catherine E. Lofton-Day, Theodore E. Whitmore
  • Publication number: 20030027253
    Abstract: Novel polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor19, a novel class II cytokine receptor. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo. The polynucleotides encoding zcytor19, are located on chromosome 1p36.11, and can be used to identify a region of the genome associated with human disease states. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.
    Type: Application
    Filed: November 28, 2001
    Publication date: February 6, 2003
    Inventors: Scott R. Presnell, Wenfeng Xu, Julia E. Novak, Theodore E. Whitmore, Francis J. Grant
  • Publication number: 20020164701
    Abstract: The present invention provides methods for identifying abnormalities in human chromosome 11 that are linked to defects in glucose metabolism. The present invention also provides methods for identifying polymorphisms in a new human gene that resides on chromosome 11q23-q24, a locus linked with a heritable form of diabetes.
    Type: Application
    Filed: October 25, 2001
    Publication date: November 7, 2002
    Inventors: Paul O. Sheppard, Laura J. Jelinek, Theodore E. Whitmore
  • Publication number: 20020045733
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions. The polypeptides of the present invention can be used to down-regulate their natural ligands. The polynucleotides and subsequences thereof can be used as diagnostic probes to determine if chromosome 19 is mutated. The antibodies which bind to the polypeptides can be used to purify the receptors and to inhibit the binding of the ligands onto the receptors.
    Type: Application
    Filed: June 13, 2001
    Publication date: April 18, 2002
    Applicant: ZymoGenetics, Inc.
    Inventors: Si Lok, Scott R. Presnell, Anna C. Jelmberg, Teresa Gilbert, Theodore E. Whitmore, Donald C. Foster, Robyn L. Adams, Joyce M. Lehner
  • Publication number: 20020042094
    Abstract: The present invention relates to polynucleotide and polypeptide molecules for zapop2, a novel human member of the RING finger protein group. The polypeptides, and polynucleotides encoding them, are expressed in specific human tissues, and may be used for detecting human chromosomal abnormalities at 1p36. The present invention also includes antibodies to the zapop2 polypeptides.
    Type: Application
    Filed: December 12, 2000
    Publication date: April 11, 2002
    Inventors: Domenick R. Venezia, David W. Taft, Theodore E. Whitmore
  • Patent number: 6271343
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions. The polypeptides of the present invention can be used to down-regulate their natural ligands. The polynucleotides and subsequences thereof can be used as diagnostic probes to determine if chromosome 19 is mutated. The antibodies which bind to the polypeptides can be used to purify the receptors and to inhibit the binding of the ligands onto the receptors.
    Type: Grant
    Filed: May 1, 1998
    Date of Patent: August 7, 2001
    Assignee: ZymoGenetics, Inc.
    Inventors: Si Lok, Scott R. Presnell, Anna C. Jelmberg, Teresa Gilbert, Theodore E. Whitmore, Donald C. Foster, Robyn L. Adams, Joyce M. Lehner
  • Patent number: 5965704
    Abstract: Novel class II cytokine receptor polypeptides, polynucleotides encoding the polypeptides, an related compositions and methods are disclosed. Th polypeptides comprise an extracellular domain of a cell-surface receptor that is expressed in pancreas, small intestine, colon and thymus. The polypeptides may be used within methods for detecting ligands that promote the proliferation and/or differentiation of these organs.
    Type: Grant
    Filed: August 5, 1997
    Date of Patent: October 12, 1999
    Assignee: ZymoGenetics, Inc.
    Inventors: Si Lok, Robyn L Adams, Anna C. Jelmberg, Theodore E. Whitmore, Theresa M. Farrah
  • Patent number: 5945511
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular domain of a cell-surface receptor that is expressed in kidneys, pancreas, prostate, adrenal cortex and nervous tissue. The polypeptides may be used within methods for detecting ligands that promote the proliferation and/or differentiation of these organs.
    Type: Grant
    Filed: October 2, 1997
    Date of Patent: August 31, 1999
    Assignee: ZymoGenetics, Inc.
    Inventors: Si Lok, Choon J. Kho, Anna C. Jelmberg, Robyn L Adams, Theodore E. Whitmore, Theresa M. Farrah